Related Experiment Video
Updated: Oct 25, 2025
10:41
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
7.6K
[Dystonia]
1Division of Speech-Language-Hearing Therapy, Department of Rehabilitation, Faculty of Health Science, Kumamoto Health Science University.
No Shinkei Geka. Neurological Surgery
|August 11, 2021
Summary
Dystonia, a movement disorder, is treated with functional neurosurgery when medical therapies fail. Deep brain stimulation and ablation techniques like MRgFUS offer options for specific dystonia types.
Area of Science:
- Neurology
- Neurosurgery
- Movement Disorders
Background:
- Dystonia is a complex network disorder affecting motor control.
- It is often refractory to conventional medical treatments.
- Functional neurosurgery is a key therapeutic strategy.
Purpose of the Study:
- To review the role of functional neurosurgery in managing dystonia.
- To highlight current surgical options and their indications.
- To discuss emerging techniques like MRgFUS.
Main Methods:
- Review of current literature on functional neurosurgery for dystonia.
- Analysis of treatment outcomes for deep brain stimulation (DBS) and ablative procedures.
- Focus on specific dystonia subtypes and targeted surgical approaches.
Main Results:
- Deep brain stimulation of the globus pallidus internus (GPi) is effective for primary and genetic dystonia.
- Thalamic surgery (Ventral Oral nucleus) is indicated for peripheral and occupational dystonia.
- Ablation, including MR-guided focused ultrasound (MRgFUS), is a last-resort option, particularly for focal hand dystonia.
Conclusions:
- Functional neurosurgery provides essential treatment options for medically refractory dystonia.
- Surgical approaches are tailored to dystonia type, with DBS and ablation offering distinct benefits.
- MRgFUS represents a promising incision-free ablation technique for focal dystonia.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
854
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
854
01:28Disorders of the Skeletal Muscle
1.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.3K
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
765
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
765
01:21Skeletal Muscle Relaxants: Adverse Effects
542
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
542
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
647
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
647
01:15Parkinson's Disease: Overview
986
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
986